Recce Pharmaceuticals Ltd (ASX:RCE)
Australia
· Delayed Price · Currency is AUD 0.2900
0.00 (0.00%)
Apr 30, 2025, 4:10 PM AEST
Recce Pharmaceuticals Balance Sheet
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | 2015 - 2019 |
| Cash & Equivalents | 1.94 | 4.42 | 1.56 | 11.58 | 20.87 | 2.68 | Upgrade
|
| Cash & Short-Term Investments | 1.94 | 4.42 | 1.56 | 11.58 | 20.87 | 2.68 | Upgrade
|
| Cash Growth | -51.51% | 182.74% | -86.52% | -44.51% | 678.21% | 564.92% | Upgrade
|
| Accounts Receivable | 0.07 | - | - | - | - | - | Upgrade
|
| Other Receivables | - | 0.16 | 0.09 | 0.18 | 0.25 | 0.04 | Upgrade
|
| Receivables | 0.49 | 0.16 | 0.09 | 0.18 | 0.25 | 0.04 | Upgrade
|
| Other Current Assets | 0.29 | 0.56 | 0.3 | 0.42 | 0.06 | 0.02 | Upgrade
|
| Total Current Assets | 3.01 | 5.14 | 1.95 | 12.18 | 21.18 | 2.74 | Upgrade
|
| Property, Plant & Equipment | 1.2 | 1.23 | 0.61 | 0.44 | 0.5 | 0.5 | Upgrade
|
| Other Intangible Assets | - | - | - | 0 | 0 | 0 | Upgrade
|
| Other Long-Term Assets | - | 0 | - | - | - | -0 | Upgrade
|
| Total Assets | 4.21 | 6.37 | 2.56 | 12.62 | 21.68 | 3.24 | Upgrade
|
| Accounts Payable | 3.37 | 3.97 | 0.95 | 0.48 | 0.49 | 0.16 | Upgrade
|
| Accrued Expenses | 0.76 | 0.57 | 0.41 | 0.38 | 0.39 | 0.41 | Upgrade
|
| Short-Term Debt | 3.96 | 9.69 | 3.05 | - | - | - | Upgrade
|
| Current Portion of Leases | 0.25 | 0.22 | 0.15 | 0.07 | 0.11 | 0.08 | Upgrade
|
| Other Current Liabilities | 0.05 | 0.62 | 0.29 | 1.51 | 0.09 | 0.23 | Upgrade
|
| Total Current Liabilities | 8.4 | 15.07 | 4.85 | 2.45 | 1.08 | 0.89 | Upgrade
|
| Long-Term Leases | 0.53 | 0.59 | 0.1 | - | 0.01 | - | Upgrade
|
| Other Long-Term Liabilities | - | - | - | 0 | - | - | Upgrade
|
| Total Liabilities | 9.19 | 15.89 | 5.14 | 2.56 | 1.18 | 0.93 | Upgrade
|
| Common Stock | 66.83 | 54.84 | 44.11 | 43.97 | 43.3 | 18.47 | Upgrade
|
| Retained Earnings | -77.81 | -70.08 | -55.54 | -42.46 | -31.47 | -17.96 | Upgrade
|
| Comprehensive Income & Other | 6 | 5.71 | 8.83 | 8.55 | 8.68 | 1.8 | Upgrade
|
| Shareholders' Equity | -4.99 | -9.52 | -2.59 | 10.06 | 20.5 | 2.31 | Upgrade
|
| Total Liabilities & Equity | 4.21 | 6.37 | 2.56 | 12.62 | 21.68 | 3.24 | Upgrade
|
| Total Debt | 4.74 | 10.5 | 3.3 | 0.07 | 0.13 | 0.08 | Upgrade
|
| Net Cash (Debt) | -2.8 | -6.09 | -1.74 | 11.51 | 20.75 | 2.6 | Upgrade
|
| Net Cash Growth | - | - | - | -44.53% | 698.25% | - | Upgrade
|
| Net Cash Per Share | -0.01 | -0.03 | -0.01 | 0.07 | 0.13 | 0.02 | Upgrade
|
| Filing Date Shares Outstanding | 231.87 | 231.61 | 196.83 | 178.02 | 173.78 | 144.17 | Upgrade
|
| Total Common Shares Outstanding | 231.87 | 203.99 | 178.25 | 177.65 | 173.78 | 136.07 | Upgrade
|
| Working Capital | -5.39 | -9.93 | -2.9 | 9.74 | 20.1 | 1.85 | Upgrade
|
| Book Value Per Share | -0.02 | -0.05 | -0.01 | 0.06 | 0.12 | 0.02 | Upgrade
|
| Tangible Book Value | -4.99 | -9.52 | -2.59 | 10.06 | 20.5 | 2.31 | Upgrade
|
| Tangible Book Value Per Share | -0.02 | -0.05 | -0.01 | 0.06 | 0.12 | 0.02 | Upgrade
|
| Machinery | 0.94 | 0.93 | 0.79 | 0.74 | 0.62 | 0.57 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.